BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1917518)

  • 1. Evaluation of the 323/A3 monoclonal antibody and the use of technetium-99m-labeled 323/A3 Fab' for the detection of pan adenocarcinoma.
    Pak KY; Nedelman MA; Fogler WE; Tam SH; Wilson E; Van Haarlem LJ; Colognola R; Warnaar SO; Daddona PE
    Int J Rad Appl Instrum B; 1991; 18(5):483-97. PubMed ID: 1917518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor imaging with technetium-99m-labeled hydrazinonicotinamide-Fab' conjugates.
    Ultee ME; Bridger GJ; Abrams MJ; Longley CB; Burton CA; Larsen SK; Henson GW; Padmanabhan S; Gaul FE; Schwartz DA
    J Nucl Med; 1997 Jan; 38(1):133-8. PubMed ID: 8998167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of cleavable and noncleavable hydrazinopyridine linkers for the 99mTc labeling of Fab' monoclonal antibody fragments.
    Bridger GJ; Abrams MJ; Padmanabhan S; Gaul F; Larsen S; Henson GW; Schwartz DA; Longley CB; Burton CA; Ultee ME
    Bioconjug Chem; 1996; 7(2):255-64. PubMed ID: 8983348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunodetection of colorectal carcinoma using technetium-99m-labeled Fab' fragments of the IMMU-4 anti-carcinoembryonic antigen monoclonal antibody.
    Moffat FL; Vargas-Cuba RD; Serafini AN; Casillas VJ; Morillo G; Benedetto P; Robinson DS; Ardalan B; Manten HD; Clark KC
    Cancer; 1994 Feb; 73(3 Suppl):836-45. PubMed ID: 8306268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive detection of atherosclerotic lesions by 99mTc-based immunoscintigraphic targeting of proliferating smooth muscle cells.
    Narula J; Petrov A; Pak KY; Ditlow C; Chen F; Khaw BA
    Chest; 1997 Jun; 111(6):1684-90. PubMed ID: 9187194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
    Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC
    Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of liver metastases of colorectal cancer with IgG, F(ab')2, and Fab' anti-carcinoembryonic antigen antibodies labeled with 99mTc: the role of metabolism and kinetics.
    Behr T; Becker W; Hannappel E; Goldenberg DM; Wolf F
    Cancer Res; 1995 Dec; 55(23 Suppl):5777s-5785s. PubMed ID: 7493346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretargeting for cancer radioimmunotherapy with bispecific antibodies: role of the bispecific antibody's valency for the tumor target antigen.
    Karacay H; Sharkey RM; McBride WJ; Griffiths GL; Qu Z; Chang K; Hansen HJ; Goldenberg DM
    Bioconjug Chem; 2002; 13(5):1054-70. PubMed ID: 12236788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of a pure 99mTc-F(ab')2 radioimmunoconjugate by direct labeling methods.
    Griffiths GL; Goldenberg DM; Jones AL; Hansen HJ
    Nucl Med Biol; 1994 May; 21(4):649-55. PubMed ID: 9234323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered pharmacokinetic and tumour localization properties of Fab' fragments of a murine monoclonal anti-CEA antibody by covalent modification with low molecular weight dextran.
    Fagnani R; Halpern S; Hagan M
    Nucl Med Commun; 1995 May; 16(5):362-9. PubMed ID: 7544884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of an "instant" 99mTc-labeling kit for antibody imaging.
    Hansen HJ; Jones AL; Sharkey RM; Grebenau R; Blazejewski N; Kunz A; Buckley MJ; Newman ES; Ostella F; Goldenberg DM
    Cancer Res; 1990 Feb; 50(3 Suppl):794s-798s. PubMed ID: 2297726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of 99mTc(Sn)- and 131I-labeled anti-carcinoembryonic antigen monoclonal antibody fragments in nude mice.
    Zimmer AM; Kazikiewicz JM; Rosen ST; Spies SM
    Cancer Res; 1987 Mar; 47(6):1691-4. PubMed ID: 3815365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99 m labelling of DD-3B6/22 antifibrin monoclonal antibody fragment Fab' for thrombus imaging.
    Lee FT; Boniface GR; Lambrecht RM; Rylatt DB; Bundesen PG
    Immunol Cell Biol; 1993 Apr; 71 ( Pt 2)():117-24. PubMed ID: 8486395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49.
    Milenic DE; Yokota T; Filpula DR; Finkelman MA; Dodd SW; Wood JF; Whitlow M; Snoy P; Schlom J
    Cancer Res; 1991 Dec; 51(23 Pt 1):6363-71. PubMed ID: 1933899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of HER2/neu expression in BT-474 human breast cancer xenografts in athymic mice using [(99m)Tc]-HYNIC-trastuzumab (Herceptin) Fab fragments.
    Tang Y; Scollard D; Chen P; Wang J; Holloway C; Reilly RM
    Nucl Med Commun; 2005 May; 26(5):427-32. PubMed ID: 15838425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site specific discrete PEGylation of (124)I-labeled mCC49 Fab' fragments improves tumor MicroPET/CT imaging in mice.
    Ding H; Carlton MM; Povoski SP; Milum K; Kumar K; Kothandaraman S; Hinkle GH; Colcher D; Brody R; Davis PD; Pokora A; Phelps M; Martin EW; Tweedle MF
    Bioconjug Chem; 2013 Nov; 24(11):1945-54. PubMed ID: 24175669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid infarct imaging with a technetium-99m-labeled antimyosin recombinant single-chain Fv: evaluation in a canine model of acute myocardial infarction.
    Nedelman MA; Shealy DJ; Boulin R; Brunt E; Seasholtz JI; Allen IE; McCartney JE; Warren FD; Oppermann H; Pang RH
    J Nucl Med; 1993 Feb; 34(2):234-41. PubMed ID: 8429342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody Fab' fragment cross-linking using equilibrium transfer alkylation reagents. A strategy for site-specific conjugation of diagnostic and therapeutic agents with F(ab')2 fragments.
    Wilbur DS; Stray JE; Hamlin DK; Curtis DK; Vessella RL
    Bioconjug Chem; 1994; 5(3):220-35. PubMed ID: 7918742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat adjuvant arthritis: imaging with technetium-99m-anti-CD4 Fab' fragments.
    Kinne RW; Becker W; Koscheck T; Kuhlmann J; Sharkey RM; Behr T; Palombo-Kinne E; Goldenberg DM; Wolf F; Emmrich F
    J Nucl Med; 1995 Dec; 36(12):2268-75. PubMed ID: 8523118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.